Search
Tamuzimod
go.drugbank.com/drugs/DB21621InvestigationalTamuzimod is under investigation in clinical trial NCT05156125 (VTX002 Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis). … Tamuzimod is a small molecule drug. The usage of the INN stem '-imod' in the name indicates that Tamuzimod is a immunomodulator, both stimulant/suppressive and stimulant.
TJ003234
go.drugbank.com/drugs/DB16470InvestigationalCategories: Experimental Unapproved Treatments for COVID-19Methylisothiazolinone
go.drugbank.com/drugs/DB15884InvestigationalSynonyms: N-Methylisothiazolin-3-oneCategories: Compounds used in a research, industrial, or household settingGlyceryl laurate
go.drugbank.com/drugs/DB16635InvestigationalCategories: Compounds used in a research, industrial, or household settingAICA ribonucleotide
go.drugbank.com/drugs/DB01700InvestigationalThe drug was first used in the 1980s as a method to preserve blood flow to the heart during surgery and is currently of interest as a potential treatment for diabetes by increasing the metabolic activity … 5-Aminoimidazole-4-carboxamide ribonucleotide (AICAR) is an intermediate in the generation of inosine monophosphate and analog of adenosine monophosphate (AMP) that is capable of stimulating AMP-dependent
Inhibitor of P38 Kinase
go.drugbank.com/drugs/DB01953ExperimentalInhibitor of P38 Kinase is a solid. This compound belongs to the indoles. These are compounds containing an indole moiety, which consists of a pyrrole ring fused to benzene to form 2,3-benzopyrrole. … This drug is known to target mitogen-activated protein kinase 14.
IMCY-0141
go.drugbank.com/drugs/DB17019InvestigationalIMCY-0141 is a synthetic peptide based on MOG (Myelin Oligodendrocyte Glycoprotein), a dominant autoantigen, designed to stop the progression of multiple sclerosis (MS) and the destruction of the myelin
Ioglunide
go.drugbank.com/drugs/DB21276ExperimentalIoglunide is a small molecule drug. Ioglunide has a monoisotopic molecular weight of 806.86 Da.
Categories: Compounds used in a research, industrial, or household settingRocakinogene sifuplasmid
go.drugbank.com/drugs/DB16316InvestigationalRocakinogene sifuplasmid is under investigation in clinical trial NCT03491683 (INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-diagnosed Glioblastoma
D-fluoromethyltyrosine F-18
go.drugbank.com/drugs/DB15296InvestigationalD-fluoromethyltyrosine F-18 is under investigation in clinical trial NCT01089998 (PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety … , Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations).